At a glance

ClinicalIndex Comparison Record

Early Ph 1Completed· 50 enrolled

Drug / intervention

Home Telehealth with Behavioral Education Componentbehavioral

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01778751

NCT01778751Early Ph 1Completed

Compare CT.gov

Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes

VA Office of Research and Development·interventional·Posted Jan 29, 2013·Updated Jan 25, 2016

In Brief

A Early Phase 1 clinical trial evaluating Home Telehealth with Behavioral Education Component for Diabetes. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study will determine whether Home Telehealth-based implementation of an evidence-based intervention targeting Veterans with persistent poorly-controlled diabetes can improve hemoglobin A1c, patient self-management, and comorbid depressive symptoms in this high-risk, high-cost population. If effective, this intervention (Advanced Comprehensive Diabetes Care) offers a feasible, sustainable, and generalizable approach to managing Veterans with persistent poorly-controlled diabetes, which can be implemented using only existing Home Telehealth services.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiabetes

CountriesUnited States

Collaborators--

Timeline

Early Ph 1CompletedFinished

20132014201520162017201820192020202120222023202420252026

First PostedJan 2013

Enrollment StartDec 2013

Primary CompletionDec 2014

TodayJul 2026

First PostedJan 29, 2013

Enrollment StartDec 1, 2013

Primary CompletionDec 1, 2014

TodayJul 2, 2026

Enrollment to primary: 1 yearPosted 13.4 years ago

Interventions

Home Telehealth with Behavioral Education Componentbehavioral

The primary effectiveness outcome for this study will be hemoglobin A1c. Secondary effectiveness outcomes will include measures of diabetes self-care, self-reported medication adherence, and depressive symptoms.